Persius/hicric huggingface dataset:
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that a Medicare plan may restrict members to a network of providers as long as medically 
necessary covered care is accessible and available through this network. The rules say that the Plan must 
arrange for and cover any medically necessary covered benefit of the plan provider network, but at in-network 
cost sharing, when an in-network provider or benefit is unavailable or inadequate to meet a member's medical 
needs. You can find this rule at 42 CFR Section 422.112(a)(1)(iii). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that, with limited exceptions, members of the Plan must use network providers to get medical care 
and services. The only exceptions are emergencies, urgently needed care when the network is not available 
(generally, when the enrollee is out of the area), out-of-area dialysis services, and cases in which the Plan 
authorizes the use of out-of-network providers. You can find this information in Chapter 3 on page 33 of the 
Plan's 2023 Evidence of Coverage.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
Medicare may cover the use of an FDA-approved drug or biological if it is safe and effective and otherwise 
reasonable and necessary for the patient. Food and Drug Administration (FDA) approved drugs used for 
indications other than what is indicated on the official label may be covered if the use is determined to be 
medically accepted, taking into consideration the major drug compendia, authoritative medical literature and/or 
accepted standards of medical practice. You can find this rule in the Centers for Medicare and Medicaid 
Services, Internet Only Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Sections 
50.4.1 and 50.4.2. 
 
The rules say that Monoclonal antibodies directed against amyloid that are approved by the Food and Drug 
Administration (FDA) for the treatment of Alzheimer's disease (AD) based upon evidence of efficacy from a 
direct measure of clinical benefit may be covered in Centers for Medicare & Medicaid Services (CMS)-
approved prospective comparative studies. Study data for CMS-approved prospective comparative studies may 
be collected in a registry. You can find this information in Medicare's National Coverage Determination 
(NCD): Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease (AD) 
(200.3). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that the thermal radiofrequency destruction of cervical, thoracic, or lumbar paravertebral facet 
joint (medial branch) nerves are considered medically reasonable and necessary for patients who meet ALL the 
following criteria: 
 
Initial thermal radiofrequency ablation (RFA): 
After the patient has had at least two (2) medically reasonable and necessary diagnostic medial branch blocks 
(MBBs), with each one providing a consistent minimum of 80 percent sustained relief of primary (index) pain 
(with the duration of relief being consistent with the agent used) AND 
Repeat thermal facet joint RFA at the same anatomic site is considered medically reasonable and necessary 
provided the patient had a minimum of consistent 50 percent improvement in pain for at least six (6) 
months or at least 50 percent consistent improvement in the ability to perform previously painful movements 
and activities of daily living (ADLs) as compared to baseline measurement using the same scale; 
Frequency Limitation: For each covered spinal region no more than two (2) radiofrequency sessions will be 
reimbursed per rolling 12 months. 
 
You can find this information in the Local Coverage Determination (LCD): Facet Joint Interventions for Pain 
Management (L35936). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that retreatment may be considered for patients who met the guidelines for initial treatment and 
subsequently developed relapse of depressive symptoms if the patient responded to prior treatments as 
evidenced by a greater than 50 percent improvement in standard rating scale measurements for depressive 
symptoms. (e.g., GDS, PHQ-9, BDI, HAM-D, MADRS, QIDS or IDS-SR scores). All other uses of 
Transcranial Magnetic Stimulation, including "maintenance therapy" are experimental and are not covered 
including TMS for the Treatment of Obsessive-Compulsive Disorder (OCD). You can find this information 
in Local Coverage Determination (LCD): Transcranial Magnetic Stimulation (TMS) (L36469). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that Medicare will cover the CologuardTM test once every three years for beneficiaries who meet 
all of the following criteria: 
 
1. Age 50 to 85 years, 
2. Asymptomatic (no signs or symptoms of colorectal disease including but not limited to lower gastrointestinal 
pain, blood in stool, positive guaiac fecal occult blood test or fecal immunochemical test), and 
3. At average risk of developing colorectal cancer (no personal history of adenomatous polyps, colorectal 
cancer, or inflammatory bowel disease, including Crohns Disease and ulcerative colitis; no family history of 
colorectal cancers or adenomatous polyps, familial adenomatous polyposis, or hereditary nonpolyposis 
colorectal cancer). 
 
You can find this rule at Centers for Medicare and Medicaid Services, National Coverage Analysis CAG-
00440N entitled "Screening for Colorectal Cancer - Stool DNA Testing." 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that plans may choose the networks of providers available to enrollees and may require enrollees 
to obtain authorization before receiving services. You can find this rule at 42 CFR Section 422.112(a) and in 
the Centers for Medicare and Medicaid Services, Internet Only Manual, Publication 100-16, Medicare 
Managed Care Manual, Chapter 1, Section 20.2. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that, with limited exceptions, members of the Plan must use network providers to get medical care 
and services. The only exceptions are emergencies, urgently needed care when the network is not available 
(generally, when the enrollee is out of the area), out-of-area dialysis services, and cases in which the Plan 
authorizes the use of out-of-network providers. You can find this information on pages 27 to 30 of the Plan's 
2023 Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
Botulinum toxin injections are used to treat various focal muscle spastic disorders and excessive muscle 
contractions such as dystonia, spasms, twitches, etc. These drugs produce a presynaptic neuromuscular 
blockade by preventing the release of acetylcholine from the nerve endings. The resulting chemical denervation 
of muscle produces local paresis or paralysis and allows individual muscles to be weakened selectively. 
Botulinum toxins have the advantage of being potent neuromuscular blocking agents with good selectivity and 
duration of action. 
 
Botulinum Toxin Type A (Botox-onabotulinumtoxinA, Xeomin -incobotulinumtoxinA and Dysport-
abotulinumtoxinA) are derived from a culture of Hall strain Clostridium Botulinum. Botulinum toxin type B 
(Myobloc  rimabotulinumtoxinB) is derived from the Bean strain of Clostridium Botulinum. Type B has the 
same action on neuromuscular conduction (blockade) as Type A. 
 
Botulinum toxin type A and botulinum toxin type B have many similarities and as experience has been gained, 
medical consensus has gradually developed that the two toxins have similar, but not identical, properties. Each 
botulinum toxin product is pharmacologically and clinically distinct, and therefore, not interchangeable with 
any other botulinum toxin product. As a result, approved indications for the two toxins differ. This A/B MAC 
has determined that the separate accepted indications for the four toxins will be combined into a single list of 
covered indications in this Local Coverage Determination (LCD) policy. However, it is the responsibility of 
providers to use each drug in accordance with the FDA approved indications unless there are valid and 
documented reasons stating why the unapproved/off label form is used, Providers should consult the package 
insert of each neurotoxin to identify the FDA approved indications for each product." 
 
You can find this rule in the Local Coverage Determination (LCD): Botulinum Toxin Types A and B Policy 
(L35170). 
 
Medicare may cover the use of an FDA-approved drug or biological if it is safe and effective and otherwise 
reasonable and necessary for the patient. Food and Drug Administration (FDA) approved drugs used for 
indications other than what is indicated on the official label may be covered if the use is determined to be 
medically accepted, taking into consideration the major drug compendia, authoritative medical literature and/or accepted standards of medical practice. You can find this rule in the Centers for Medicare and Medicaid 
Services, Internet Only Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Sections 
50.4.1 and 50.4.2. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101.

The rules say that the provider, supplier, or beneficiary, as appropriate, must furnish to the intermediary or carrier sufficient information to determine whether payment is due and the amount of payment. You can find this rule at 42 CFR 424.5. 

The rules say for Medicare to consider coverage and payment for any item or service, the information submitted by the supplier or provider must corroborate the documentation in the beneficiary's medical documentation and confirm that Medicare coverage criteria have been met. You can see this in the Centers for Medicare and Medicaid Services, Internet Only Manual, Publication 100-08, Medicare Program Integrity Manual, Chapter 3, Section 3.3.2.1.

If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.

The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101.

The rules say that ventilators may be covered when they are medically necessary for patients who have neuromuscular disease, thoracic restrictive diseases, and chronic respiratory failure due to chronic obstructive pulmonary disease (COPD). You can find this rule in the Centers for Medicare and Medicaid Services, Internet Only Manual, Publication 100-03, Medicare National Coverage Determinations Manual, Chapter 1, Section 280.1. The rules also say that the decision to use a ventilator or a bi-level positive airway pressure (BiPAP) device is made based upon the specifics of each person's medical condition. There must be enough detailed information in the medical record to justify the treatment selected. Ventilators fall under the Frequent and Substantial Servicing (FSS) payment category, and payment policy requirements preclude FSS payment for devices used to deliver continuous and/or intermittent positive airway pressure, regardless of the illness treated by the device. This means that products currently classified as Healthcare Common Procedure Coding System (HCPCS) code E0465, E0466, or E0467 when used to provide continuous positive airway pressure (CPAP) or BiPAP (with or without backup rate) therapy, regardless of the underlying medical condition, shall not be paid in the FSS payment category and will be denied as not reasonable and necessary. You can find this rule in the Local Coverage Determination (LCD): Respiratory Assist Devices (L33800).

If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.

The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare will not pay for dental services. Dental services are items and services involving 
the care, treatment, filling, removal or replacement of teeth or structures directly supporting the teeth. Medicare 
defines "structures directly supporting the teeth" as the periodontium, which includes the gingivae, 
dentogingival junction, periodontal membrane, cementum of the teeth, and alveolar process. You can find this 
rule in the Social Security Act, Section 1862(a)(12) and in the Centers for Medicare and Medicaid Services, 
Internet Only Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 150. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract 
says that the Plan covers certain dental services as a supplemental (extra) benefit. This benefit includes the 
requested item or service but the claim for reimbursement must be submitted within 120 days of the date of 
service. You can find this information on page 83 of the Plan's 2023 Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that a Medicare plan may restrict members to a network of providers as long as medically 
necessary covered care is accessible and available through this network. The rules say that the Plan must 
arrange for and cover any medically necessary covered benefit of the plan provider network, but at in-network 
cost sharing, when an in-network provider or benefit is unavailable or inadequate to meet a member's medical 
needs. You can find this rule at 42 CFR Section 422.112(a)(1)(iii). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that, with limited exceptions, members of the Plan must use network providers to get medical care 
and services. The only exceptions are emergencies, urgently needed care when the network is not available 
(generally, when the enrollee is out of the area), out-of-area dialysis services, and cases in which the Plan 
authorizes the use of out-of-network providers. You can find this information in Chapter 3 on pages 29 and 30 
of the Plan's 2023 Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that program reimbursement for hyperbaric oxygen (HBO) therapy will be limited to that which 
is administered in a chamber (including the one man unit. It can be covered for diabetic wounds of the lower 
  
  extremities in patients who meet the following three criteria: 
 
a. Patient has type I or type II diabetes and has a lower extremity wound that is due to diabetes; 
b. Patient has a wound classified as Wagner grade III or higher; and 
c. Patient has failed an adequate course of standard wound therapy. 
 
You can find this rule in the National Coverage Determination (NCD) - Hyperbaric Oxygen Therapy (20.29). 
 
The rules say that the use of HBO therapy is covered as adjunctive therapy only after there are no measurable 
signs of healing for at least 30 days of treatment with standard wound therapy and must be used in addition to 
standard wound care. Standard wound care in patients with diabetic wounds includes: assessment of a patients 
vascular status and correction of any vascular problems in the affected limb if possible, optimization of 
nutritional status, optimization of glucose control, debridement by any means to remove devitalized tissue, 
maintenance of a clean, moist bed of granulation tissue with appropriate moist dressings, appropriate off-
loading, and necessary treatment to resolve any infection that might be present. Failure to respond to standard 
wound care occurs when there are no measurable signs of healing for at least 30 consecutive days. Wounds 
must be evaluated at least every 30 days during administration of HBO therapy. Continued treatment with HBO 
therapy is not covered if measurable signs of healing have not been demonstrated within any 30-day period of 
treatment. You can find this rule in the National Coverage Determination (NCD) - Hyperbaric Oxygen Therapy 
(20.29). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that physical therapy (PT), occupational therapy (OT), and speech therapy (ST) services are 
covered only when they are medically reasonable and necessary. Therapy services are considered reasonable 
and necessary when: 
 
1. The services are specific and effective treatment for the patient's condition, 
2. The services require the skills or direct supervision of a therapist,  
3. The amount, frequency, and duration of the services is reasonable under accepted standards of practice, and   
4. The services are needed to address recovery of or improvement in function OR to establish, design, deliver, 
or carry out a maintenance program.  
 
Medicare coverage is based not on a patient's potential for improvement, but rather on the patient's need for 
skilled care. You can find these rules in the Centers for Medicare and Medicaid Services, Internet Only 
Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 220.2. 
 
The local Medicare Administrative Contractor has published its interpretation of the various outpatient therapy 
rules which provide more specific criteria for certain services. You can find this information in the Local 
Coverage Determination (LCD): Outpatient Physical and Occupational Therapy Service L33361 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that providers that render services or items to a prisoner indicate this fact with the use of 
modifier QJ.  You can find this rule at Centers for Medicare and Medicaid Services, Internet-Only Publication 
100-04, Medicare Claims Processing Manual, Chapter 1, Section 10.4. 
 
The rules state that Medicare does not pay for services furnished to individuals in custody of penal authorities.  
You can find this rule at 42 CFR 411.4(b).  
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare will not pay for dental services. Dental services are items and services involving 
the care, treatment, filling, removal or replacement of teeth or structures directly supporting the teeth. Medicare 
defines "structures directly supporting the teeth" as the periodontium, which includes the gingivae, 
dentogingival junction, periodontal membrane, cementum of the teeth, and alveolar process. You can find this 
rule in the Social Security Act, Section 1862(a)(12) and in the Centers for Medicare and Medicaid Services, 
Internet Only Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 150. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract 
says that the Plan covers certain dental services as a supplemental (extra) benefit. This benefit includes a 
$1,000 annual dental maximum allowance for covered dental benefits. You can find this information on page 
115 of the Plan's 2023 Evidence of Coverage (EOC).